Pharma Mar (UK) Market Value
| 0RC6 Stock | 72.55 2.34 3.12% |
| Symbol | Pharma |
Pharma Mar 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharma Mar's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharma Mar.
| 11/28/2023 |
| 11/22/2024 |
If you would invest 0.00 in Pharma Mar on November 28, 2023 and sell it all today you would earn a total of 0.00 from holding Pharma Mar SAU or generate 0.0% return on investment in Pharma Mar over 360 days. Pharma Mar is related to or competes with Litigation Capital, Check Point, Albion Technology, Allianz Technology, Spirent Communications, Playtech Plc, and Verizon Communications. Pharma Mar is entity of United Kingdom. It is traded as Stock on LSE exchange. More
Pharma Mar Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharma Mar's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharma Mar SAU upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.24 | |||
| Information Ratio | 0.2398 | |||
| Maximum Drawdown | 24.67 | |||
| Value At Risk | (3.12) | |||
| Potential Upside | 6.09 |
Pharma Mar Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharma Mar's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharma Mar's standard deviation. In reality, there are many statistical measures that can use Pharma Mar historical prices to predict the future Pharma Mar's volatility.| Risk Adjusted Performance | 0.2132 | |||
| Jensen Alpha | 0.9437 | |||
| Total Risk Alpha | 0.509 | |||
| Sortino Ratio | 0.4004 | |||
| Treynor Ratio | 1.86 |
Pharma Mar SAU Backtested Returns
Pharma Mar appears to be very steady, given 3 months investment horizon. Pharma Mar SAU maintains Sharpe Ratio (i.e., Efficiency) of 0.25, which implies the firm had a 0.25% return per unit of risk over the last 3 months. By analyzing Pharma Mar's technical indicators, you can evaluate if the expected return of 0.95% is justified by implied risk. Please evaluate Pharma Mar's Risk Adjusted Performance of 0.2132, semi deviation of 1.52, and Coefficient Of Variation of 371.64 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharma Mar holds a performance score of 19. The company holds a Beta of 0.54, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharma Mar's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharma Mar is expected to be smaller as well. Please check Pharma Mar's semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to make a quick decision on whether Pharma Mar's historical price patterns will revert.
Auto-correlation | -0.39 |
Poor reverse predictability
Pharma Mar SAU has poor reverse predictability. Overlapping area represents the amount of predictability between Pharma Mar time series from 28th of November 2023 to 26th of May 2024 and 26th of May 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharma Mar SAU price movement. The serial correlation of -0.39 indicates that just about 39.0% of current Pharma Mar price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.69 | |
| Residual Average | 0.0 | |
| Price Variance | 201.12 |
Pharma Mar SAU lagged returns against current returns
Autocorrelation, which is Pharma Mar stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharma Mar's stock expected returns. We can calculate the autocorrelation of Pharma Mar returns to help us make a trade decision. For example, suppose you find that Pharma Mar has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Pharma Mar regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharma Mar stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharma Mar stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharma Mar stock over time.
Current vs Lagged Prices |
| Timeline |
Pharma Mar Lagged Returns
When evaluating Pharma Mar's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharma Mar stock have on its future price. Pharma Mar autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharma Mar autocorrelation shows the relationship between Pharma Mar stock current value and its past values and can show if there is a momentum factor associated with investing in Pharma Mar SAU.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pharma Stock Analysis
When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.